哮喘与妊娠期高血压疾病的关联:Nulliparous Pregnancy Outcomes Study: monitoring mothers-to-be(nuMoM2b)前瞻性队列研究的二次分析
该研究为nuMoM2b前瞻性多中心队列的二次分析,纳入8741例无活产史且本次为单胎活产的参与者,其中1521例(17.4%)在早孕期报告哮喘诊断。校正混杂因素后,哮喘与妊娠期高血压疾病风险升高相关(aOR 1.23,95%CI 1.06-1.42),活动性哮喘还与自发性早产风险升高相关(aOR 1.60,95%CI 1.30-1.96)。
要点
- 哮喘诊断与妊娠期高血压疾病风险升高相关(aOR 1.23,95%CI 1.06-1.42)。
- 活动性哮喘与子痫前期风险升高相关(aOR 1.27,95%CI 1.07-1.51)。
- 活动性哮喘与自发性早产风险升高相关(aOR 1.60,95%CI 1.30-1.96)。
核心结论
- 在具有多样性的全国代表性无活产史人群中,哮喘诊断与妊娠期高血压疾病风险显著升高相关。
- 活动性哮喘增加自发性早产和妊娠期高血压疾病的风险。
- 该分析支持将活动性哮喘识别为与未来心血管疾病风险较高相关的妊娠不良结局的危险因素。
研究设计与样本
- 研究为nuMoM2b前瞻性多中心队列的二次分析,该队列在孕60/7至136/7周招募无活产史、单胎妊娠且胎儿存活的个体。
- 本二次分析纳入年龄18岁及以上、有活产且无孕前高血压或糖尿病史的个体,共8741例。
- 活动性哮喘定义为早孕期访视时自报哮喘病史且目前使用哮喘治疗(包括支气管扩张剂、吸入性类固醇或免疫调节剂)。
- 主要结局为妊娠期高血压疾病,次要结局为其他妊娠不良结局。
- 采用单因素和多因素logistic回归,报告比值比(OR)和校正比值比(aOR)及95%置信区间(95%CI);模型校正母亲年龄、研究site、保险类型(社会经济地位标志)和早孕期访视时吸烟状态;种族/民族和体重指数(BMI)未纳入完全校正模型。
主要发现
- 8741例参与者中,1521例(17.4%)在早孕期访视时报告哮喘诊断,其中588例(38.7%)报告使用任何哮喘药物。
- 哮喘组与无哮喘组相比,孕前三个月报告吸烟的比例更高(20.7% vs 16.5%)。
- 单因素logistic回归显示,哮喘诊断与妊娠期高血压疾病风险显著升高相关(OR 1.21,95%CI 1.04-1.42)。
- 校正后,妊娠期高血压疾病风险仍显著升高(aOR 1.23,95%CI 1.06-1.42),具体为子痫前期(aOR 1.21,95%CI 1.02-1.45)。
- 活动性哮喘参与者的二次分析显示,妊娠期高血压疾病风险显著升高(aOR 1.32,95%CI 1.06-1.65),包括子痫前期(aOR 1.27,95%CI 1.07-1.51),此外自发性早产风险也升高(aOR 1.60,95%CI 1.30-1.96)。
临床怎么用
- 原文结论指出,该分析支持将活动性哮喘识别为与未来心血管疾病风险较高相关的妊娠不良结局的危险因素。
- 原文未据此给出具体的临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE:: Asthma is one of the most common comorbid conditions in pregnancy. While asthma has been identified as an independent risk factor for cardiovascular disease in the general population, the influence of active asthma during pregnancy on future cardiac risk is unclear. Growing evidence has linked maternal active asthma to adverse pregnancy outcomes (APOs), such as hypertensive disorders of pregnancy (HDP), including preeclampsia which is a well-defined risk factor for future cardiovascular disease including altered cardiac structure and diastolic dysfunction. A thorough understanding of the relationship between pre-existing asthma and APOs may be instrumental in identifying upstream factors contributing to lifetime maternal cardiovascular risk. However, current knowledge of these relationships has been largely derived from retrospective clinical studies, which limit the precision of capturing APOs. Therefore, we investigated associations between pre-existing asthma and individual subtypes of APOs in a secondary analysis of a prospective multi-center cohort of nulliparous individuals with rigorously adjudicated pregnancy outcomes. STUDY DESIGN:: We included participants from the multisite Nulliparous Outcomes in Pregnancy: Monitoring Mothers to be (nuMom2b) cohort, which recruited nulliparous individuals with a viable, singleton gestation between 60/7 and 136/7 weeks. Details of the study design have been previously described, which included medical histories in standardized interviews. This secondary analysis included individuals aged 18 years or older with a live birth and excluded those with a history of pre-pregnancy hypertension or diabetes. For the purposes of this analysis, we defined active asthma as a self-reported history of asthma and on current asthma treatment, including use of bronchodilator, inhaled steroid, or immune modulator, captured at the first trimester visit. The primary outcome was HDP and secondary outcomes included other APOs. Characteristics between participants who did and did not have asthma were compared. Univariate and multivariate logistic regression, described using odds ratios (ORs) and adjusted ORs (aORs) and 95% confidence intervals (95% CI), was used to determine risk of APOs. Models were adjusted for maternal age, study site, insurance type (marker of socioeconomic status), and smoking status at the first trimester visit. Race/ethnicity and body mass index (BMI) were excluded from fully adjusted models as race/ethnicity was considered as a factor reflective of the social determinants of health and BMI was conceptualized as within the casual pathway for developing HDP. The study was approved by all local institutional review boards, and participants gave written informed consent. Analyses were conducted using STATA (MP 17, College Station, TX). RESULTS: Of 8,741 individuals included, 1,521 (17.4%) reported a diagnosis of asthma at the first trimester visit, of whom 588 (38.7%) reported the use of any asthma medication. When comparing participants with and without asthma, a higher proportion of those with asthma reported smoking tobacco in the three months prior to pregnancy (20.7% vs 16.5%) (Table 1). Univariate logistic regression revealed that a diagnosis of asthma was associated with a significantly higher risk of HDP (OR: 1.21 [1.04, 1.42]). Following adjustment, risk of HDP remained significantly higher (aOR: 1.23 [1.06, 1.42]), specifically preeclampsia (aOR: 1.21, [1.02, 1.45]). Secondary analyses in participants with active asthma (ie additional reported use of asthma medication during or before the first trimester) demonstrated a significantly higher risk of HDP (aOR 1.32 [1.06–1.65]) including preeclampsia (aOR 1.27 [1.07–1.51]; in addition to spontaneous preterm birth (aOR 1.60 [1.30–1.96]). CONCLUSIONS: In a diverse, nationally representative sample of nulliparous individuals,, a diagnosis of asthma was associated with a significantly higher risk of HDP. Active asthma increased the risk of both spontaneous preterm birth and HDP. This analysis supports the importance of identifying active asthma as a risk factor for APOs associated with a higher risk of future cardiovascular disease.
引用
- Meislin R, Bose S, Huang X, et al. Association between asthma and hypertensive disorders of pregnancy: a secondary analysis of the Nulliparous Pregnancy Outcomes Study: monitoring mothers-to-be (nuMoM2b) prospective cohort study. Am J Obstet Gynecol MFM. 2023. PMID: 37660759. doi:10.1016/j.ajogmf.2023.101147
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。